Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPerm Tsb Grp Regulatory News (PTSB)

Share Price Information for Perm Tsb Grp (PTSB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.525
Bid: 1.49
Ask: 1.56
Change: 0.00 (0.00%)
Spread: 0.07 (4.698%)
Open: 1.525
High: 0.00
Low: 0.00
Prev. Close: 1.525
PTSB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

18 Apr 2023 09:08

RNS Number : 5775W
Morgan Stanley & Co. Int'l plc
18 April 2023
 

18 April 2023

Permanent TSB Group Holdings p.l.c.

Pre-stabilisation Period Announcement

Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Matteo Benedetto; telephone: +44 20 7677 3409) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 and/or the UK FCA Stabilisation Binding Technical Standards.

Securities

Issuer:

Permanent TSB Group Holdings p.l.c.

Guarantor (if any):

N/A

Aggregate nominal amount:

TBC

 

Description:

Euro 5NC4 Fixed Rate Senior Notes due 2028

 

Offer price:

TBC

Stabilisation

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

BofA Securities Europe SA

Goldman Sachs International

UBS Europe SE

Stabilisation period expected to start on:

18 April 2023

Stabilisation period expected to end no later than:

25 May 2023

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable laws and rules.

Stabilisation trading venue:

Irish Stock Exchange Regulated Market (Euronext Dublin)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAIPMPTMTMBMFJ
Date   Source Headline
15th May 20245:00 pmRNSResult of AGM
8th May 20247:00 amRNSTrading Statement
3rd May 20241:52 pmRNSStabilisation Notice
2nd May 20242:00 pmRNSHolding(s) in Company
2nd May 20242:00 pmRNSDirector/PDMR Shareholding
25th Apr 20243:30 pmRNSDirector/PDMR Shareholding
25th Apr 20243:30 pmRNSDirector/PDMR Shareholding
25th Apr 20242:30 pmRNSDirector/PDMR Shareholding
4th Apr 20242:00 pmRNSNotice of AGM
3rd Apr 20249:56 amRNSStabilisation Notice
13th Mar 20243:15 pmRNSHolding(s) in Company
7th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Annual Financial Results
7th Mar 20247:00 amRNSAnnual Financial Report
15th Dec 20232:00 pmRNS2023 SREP Outcome: Position on Distributions
14th Dec 20233:00 pmRNSDirector Declaration
14th Dec 20233:00 pmRNSDirector Declaration
12th Dec 20234:30 pmRNSDirectorate Changes
23rd Nov 20232:00 pmRNSIdentification as an O-SII and Associated Buffer
25th Oct 20237:00 amRNSTrading Statement - Q3 2023
20th Oct 20235:00 pmRNSHolding(s) in Company
20th Oct 20235:00 pmRNSHolding(s) in Company
4th Aug 20239:00 amRNSNotice of Redemption ISIN: XS2056560571
2nd Aug 20237:00 amRNSHalf-year Report
2nd Aug 20237:00 amRNSCommentary on 2023 Half-Year Report
26th Jul 20232:38 pmRNSStabilisation Notice
26th Jun 20239:40 amRNSStabilisation Notice
13th Jun 202310:00 amRNSHolding(s) in Company
7th Jun 20232:00 pmRNSHolding(s) in Company
7th Jun 20232:00 pmRNSHolding(s) in Company
6th Jun 20232:00 pmRNSHolding(s) in Company
6th Jun 20232:00 pmRNSHolding(s) in Company
2nd Jun 20237:33 amRNSStatement on Share Sale
19th May 20234:49 pmRNSResult of AGM
18th May 202312:39 pmRNSStabilisation Notice
2nd May 20237:00 amRNSTrading Statement
18th Apr 20239:08 amRNSStabilisation Notice
31st Mar 20233:00 pmRNSNotice of AGM
31st Mar 20239:00 amRNSBoard Chair Appointment Takes Effect
28th Mar 20235:15 pmRNSChange of Ticker Symbol (TIDM)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.